Navigation Links
Air Products Reports Q1 EPS Up 16% on Volume Growth and Improved Margins; Raises 2008 Full Year EPS Guidance
Date:1/23/2008

Access the Q1 earnings teleconference today at 10:00 a.m. EST by calling (719) 325-4826 and entering passcode 8101417, or listen on the Web at:

http://www.airproducts.com/Invest/financialnews/EarningsReleases.htm.

LEHIGH VALLEY, Pa., Jan. 23 /PRNewswire-FirstCall/ -- Air Products (NYSE: APD) today reported net income of $264 million, or diluted earnings per share (EPS) of $1.19, for its fiscal first quarter ended December 31, 2007. Net income increased 15 percent, and diluted EPS increased 16 percent compared with the prior year.

These results include $0.03 of discontinued operations related to a previously announced definitive agreement to divest Air Products' interest in its polymers joint ventures to Wacker Chemie AG and the completed sale of the company's High Purity Process Chemicals (HPPC) business to KMG Chemicals during the quarter. On a continuing operations basis, net income increased 16 percent, and diluted EPS increased 17 percent.

First quarter revenues of $2,474 million were up nine percent from the prior year on higher volumes, improved pricing across most segments, and a weaker dollar. Operating income of $372 million was up 17 percent versus the prior year.

John McGlade, president and chief executive officer, said, "Our fiscal year is off to a great start, thanks to the dedication and commitment of our 22,000 employees worldwide. We delivered double-digit earnings growth and significant margin improvement during the quarter. This strong performance reflects the continued emphasis we have placed on delivering profitable growth through our global focus and relentless drive for productivity."
'/>"/>

SOURCE Air Products
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine news :

1. Makers of OTC Cough Medicines Reaffirm Efficacy of Products
2. DSS Announces Market Research Program for the Design of 2009 MA and PDP Products and Marketing Programs
3. Jan Marini Skin Research Suspends Sales of Popular Eyelash Products
4. Fusion Energy Teams Up With BPs am/pm Stores to Enhance Supercross Sponsorship and Fusion Energy Products Distribution
5. U.S. Food Safety: A Grocery List of Tainted Products
6. Statement From the Consumer Healthcare Products Association on the SAMHSA Findings on Cough Medicine Abuse
7. Align Technology Previews New Invisalign Products at JPMorgan Healthcare Conference
8. ReBuilder Medical Technologies, Inc. Expands R&D of New Products
9. Stress reduction products and services that are effective and safe
10. New ingredients in drug-like anti-aging products improve skin
11. Varian Medical Systems Acquires Pan-Pacific Enterprises for Marketing, Sales and Distribution of X-Ray Imaging Products in China

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)... The award-winning docume...ision debut on the Sundance Channel on World Diabe... Directed by Academy Award® nominee Edward La...ith type 1 diabetes amid the verdant mountains and...t countries. The children are supported with life-...
(Date:11/9/2009)...9 Speaker Nancy Pelosi...ons in the Affordable Health Care for America ...id and reduce Medicare Part D costs for people liv...aturday by a vote of 220 to 215: ,, "Effective...lity of life for thousands of Americans living wit...
(Date:11/9/2009)...rt Experimental Procedure for Preteen Son - ,...For parents of children with cancer, the hopeful n... improved for decades. Among the bad news -- treat.... ,, Boys diagnosed with cancer who have reac...rve their fertility: before undergoing cancer trea...
(Date:11/9/2009)...l use funds to move lab findings into human therap...ain from nerve damage ,, ANN ARBOR, Mich., Nov... University of Michigan Department of Neurology ha...l therapy for neuropathic pain, a difficult-to-tre...ause of damage to nerve without obvious tissue inj...
(Date:11/9/2009)...r 9, 2009 Shire plc (LSE: SHP, NASDAQ: SHPGY), th...y announced the availability of INTUNIV (guanfacin...he United States for the treatment of Attention-De...d adolescents ages 6 to 17. INTUNIV, a once-daily...nonscheduled alpha-2A receptor agonist approved fo...
Breaking Medicine News(10 mins):Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 2Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 3Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 4Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 5Health News:Award-winning Diabetes Documentary to Make World TV Premiere on Sundance Channel on World Diabetes Day 6Health News:Pelosi Applauds Provisions in Health Bill to Improve Access to Care, Medications for People Living With HIV/AIDS 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 2Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 3Health News:For Young Boys With Cancer, Testicular Tissue Banking May Be Option to Preserve Fertility 4Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 2Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 3Health News:Once-daily INTUNIV (guanfacine) extended release tablets now available in US pharmacies 4
...mail intervention program is an effective way to s... helping people move more, sit less, and make heal...te Division of Research study in the American Jou...g 787 Kaiser Permanente Northern California employ...
...cancer bringing total raised by LIFE to $5.6 milli...ros including World Golf Hall of Fame members Beth... Stanford, Morgan Pressel, Brittany Lincicome, Hel...ast Cancer) Event hosted by LPGA veteran Val Skinn...
...ewswire-Asia-FirstCall/ -- BMP Sunstone,Corporatio...y"), today announced,financial results for the fir...Highlights from the First Quarter Ended March 31, ....7 million from $7.7 million in the prior, y...
...es, Inc. (Nasdaq: GTIV ), a leading provider of ... that on May 14, 2009 it received official notific...ce with the exchange,s independent director requir...ows: , , , until the earlier of the Com...
...ls, Inc. (Nasdaq: TRBN ) announced today that da...dy (15002) of TRU-015 for rheumatoid arthritis wil...gue Against Rheumatism (EULAR) annual meeting in C...TRUBIONLOGO ) , , Data from the first course of r...
...y Corporation, (Nasdaq: QG L Y), www.quigley...any,s possible alternative strategies going forwar...rding the unexpected positive finding for its QR-3...al are awaited, the Company,s Board of Directors a...
Other Medicine News:Health News:Workplace e-mail intervention program helps people sit less and eat better 2Health News:Workplace e-mail intervention program helps people sit less and eat better 3Health News:LIFE 10th Anniversary Event Delivers Big Names and Big Dollars for Breast Cancer Fight 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 2Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 3Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 4Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 5Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 6Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 7Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 8Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 9Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 10Health News:BMP Sunstone Reports First Quarter 2009 Financial Results 11Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 2Health News:Gentiva(R) Health Services Receives Nasdaq Notification Regarding Independent Director Requirement 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 2Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 3Health News:Trubion Pharmaceuticals, Inc. to Present Positive Data From a Phase 2b Re-treatment Study of TRU-015 at the 2009 EULAR Annual Meeting 4Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 2Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 3Health News:The Quigley Corporation Announces Update on Strategic Alternatives and Commitment to Additional Review of Current Cost Structure 4
(Date:11/9/2009)...INCETON JUNCTION, N.J., Nov. 9 Unw...edical devices, but recognizing today,s economic c...h quality aesthetic laser systems, introduces the ...priced at under $50,000. ,, The MOSAIC CO2 off...tional technology including scanning and stamping ...
(Date:11/9/2009)...N ARBOR, Mich., Nov. 9 Thomson R...cal Xpert(TM) CareFocus, a leading clinical survei... at-risk patients in real-time and respond immedia...cost of treatment. ,, This upgrade is available...ost. ,, CareFocus 2.0 contains several powerf...
(Date:11/9/2009)...NNYVALE, Calif., Nov. 9 ...eutical company focused on developing and commerci...eatment of immune mediated diseases and cancer, to..., Preclinical Development will provide an overview...man Curhan Ford,s 6th Annual Investor Summit. ,...
Breaking Medicine Technology:Lutronic(R) Unleashes the New MOSAIC CO2 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 2Thomson Reuters Clinical Surveillance Solution Offers Powerful New Functionality to Improve Clinical Quality and Reduce Costs 3Pharmacyclics to Present at Merriman Curhan Ford's Investor Summit 2009 2Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 1Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 2Tolerx Presents Otelixizumab Phase 2 Dose Optimization Data At The IDFs 20th World Diabetes Congress 14567 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 1CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 2CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 3CDC Advisory Committee Recommends Cervarix To Prevent Cervical Cancer in Girls and Young Women 5650 4Alzheimers lesions found in the retina 59918 1Alzheimers lesions found in the retina 59918 2
...30 Peptimmune, Inc. a privately,held biotechnolog...Number,7,381,790 (the ,790 patent) which protects ...copolymer for the treatment of autoimmune diseases...cending dose,double-blind, placebo-controlled rand...Following establishment of safety at potentially t...
... 30 Wound Care Innovations, LLC,a subsidiary of W...Board:,WNDM), announced today an evidence based st...ical performance of their advanced wound care coll...lcers. "According to data,released by the Centers ...ffects nearly 24 million people in the United Stat...
Other Medicine Technology:Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 2Peptimmune Announces Grant of United States Patent for PI-2301 Peptide Copolymer for Multiple Sclerosis 3Wound Management Technologies, Inc. Announces Agreement for Evidence Based Study for Diabetic Venous Ulcers 2
...nitoring System™ expands hospital-grade moni...ields of subacute care and disease state managemen...ss a full range of clinical applications, from con...e hospital, to periodic monitoring of patients out...
...ess capability to Welch Allyn's comprehensive hard...onitoring concept to provide vital signs data and ...xNet links multiple devices such as ambulatory wir...monitors to Acuity® Central Monitoring Station...
Wireless Propaq® CS
Vital Signs Monitor
Medicine Products: